Annexon Inc (ANNX)
4.82
-0.06
(-1.23%)
USD |
NASDAQ |
May 06, 16:00
4.81
-0.01
(-0.21%)
After-Hours: 20:00
Annexon Free Cash Flow: -121.34M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -121.34M |
September 30, 2023 | -125.27M |
June 30, 2023 | -127.85M |
March 31, 2023 | -120.46M |
December 31, 2022 | -122.84M |
September 30, 2022 | -124.59M |
June 30, 2022 | -124.18M |
March 31, 2022 | -119.79M |
December 31, 2021 | -107.76M |
Date | Value |
---|---|
September 30, 2021 | -98.02M |
June 30, 2021 | -81.39M |
March 31, 2021 | -67.02M |
December 31, 2020 | -53.55M |
September 30, 2020 | -43.01M |
June 30, 2020 | -36.17M |
March 31, 2020 | -32.62M |
December 31, 2019 | -28.36M |
Free Cash Flow Range, Past 5 Years
-127.85M
Minimum
Jun 2023
-28.36M
Maximum
Dec 2019
-90.25M
Average
-107.76M
Median
Dec 2021
Free Cash Flow Benchmarks
Trxade Health Inc | -2.074M |
P3 Health Partners Inc | -77.86M |
Arrowhead Pharmaceuticals Inc | -402.70M |
Insmed Inc | -549.54M |
Heron Therapeutics Inc | -60.33M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -23.48M |
Cash from Investing (Quarterly) | -2.183M |
Cash from Financing (Quarterly) | 117.60M |
Free Cash Flow Per Share (Quarterly) | -0.3001 |
Free Cash Flow Yield | -33.27% |